Garrison currently serves as EVP and president of the Medical Essentials and BioPharma Systems segments at BD. His retirement goes into effect on Oct. 2.
Over more than two decades at BD, Garrison held a range of leadership roles. Those include EVP and president of BD’s Medical segment, worldwide president of Medication Management Solutions and worldwide president of Surgery. Before joining BD in 2005, he held various roles in R&D and marketing capacities within medtech.
“Mike has made a significant impact on BD over the past two decades, helping guide our company through periods of transformation while always keeping our customers, patients and associates at the center of his decisions,” said Tom Polen, chair, CEO and president. “He has built strong teams, developed exceptional leaders and helped position our business for the future. We are grateful for Mike’s leadership, partnership and many contributions to BD, and we wish him well in his retirement.”
Franklin Lakes, New Jersey-based BD said it plans for Garrison to remain in his role through the end of its fiscal year. The company has a comprehensive search underway to find his successor. Going forward, the BioPharma Systems unit reports directly to Polen to streamline the company’s operating model.
“It has been a privilege to spend more than two decades at BD, working alongside talented teams who are deeply committed to improving healthcare around the world,” Garrison said. “I will always value the people, purpose and impact that have made my time at BD so meaningful, and I look forward to seeing the company continue to advance the future of care.”
